FCSC - Fibrocell Science, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue355492180
Cost of Revenue6977222,312
Gross Profit-342-230-2,132
Operating Expenses
Research Development12,12425,89217,735
Selling General and Administrative9,77311,28510,087
Non Recurring4,2404,2404,240
Total Operating Expenses---
Operating Income or Loss-26,479-37,407-29,954
Income from Continuing Operations
Total Other Income/Expenses Net11,4152,9544,304
Earnings Before Interest and Taxes-15,064-34,453-25,650
Interest Expense228228228
Income Before Tax-15,292-34,453-25,650
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-15,292-34,453-25,650
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-15,292-34,453-25,650
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-15,292-34,453-25,650